| | | | | |
| €27,1544 | -0,05 % | €240,17M | €34,43K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12,0639 | +0,00 % | €239,87M | €28,65K | |
TSI TCW Strategic Income Fund, Inc. | €3,7330 | -0,34 % | €239,48M | €278,16K | |
PAII Pyrophyte Acquisition Corp. II | €8,8017 | +0,20 % | €239,06M | €5,993 | |
| €12,5176 | +0,00 % | €238,94M | €281,59K | |
YDES YD Bio Limited Ordinary Shares | €4,2039 | +2,59 % | €238,94M | €30,12K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,5526 | -0,01 % | €238,63M | €25,68 | |
RWAY Runway Growth Finance Corp. Common Stock | €5,6809 | +0,53 % | €238,62M | €405,79K | |
JILL J.Jill, Inc. Common Stock | €17,3038 | -0,54 % | €238,61M | €40,13K | |
LCTX Lineage Cell Therapeutics, Inc. | €0,92470 | +0,00 % | €238,19M | €583,84K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,8317 | +0,05 % | €238,12M | €20,45K | |
ACV Virtus Diversified Income & Convertible Fund | €22,5437 | -1,27 % | €238,10M | €17,64K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7424 | +2,26 % | €237,96M | €314,56K | |
| €1,2244 | +5,93 % | €237,88M | €906,35K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2,5686 | +0,67 % | €237,73M | €53,81K | |
